Centre Forms 5-Member Panel To Examine Manufacturing Of Nutraceuticals Within Drug Production Facility

Bengaluru: Union government has now formed a committee to examine the matter of manufacturing of nutraceuticals within the drug manufacturing facility. This follows the implementation of revised Schedule M mandating dedicated areas for manufacture of nutraceuticals and pharmaceuticals.

In this regard a committee has been constituted comprising A Visala, Joint Drugs Controller (I) CDSCO, Ranga Chandrashekar, Joint drugs controller CDSCO (HQ), AK Pradhan, advisor, CDSCO, (HQ), Arvind Kumar Bansal, NIPER, Mohali and SM Mudda, industry expert.

The communication from the government has stated that enforcement division of the CDSCO (HQ) will provide the secretariat assistance to the committee. The committee will submit their report within a period of three weeks. All the members of the committee will need to adhere to the principles of confidentiality.

India is the pharmacy of the world, said industry sources and went on to state that so far multivitamins and minerals have been manufactured in the same facility that produces medicines. Globally, both nutraceuticals and pharmaceuticals are manufactured at the same facility. The formation of committee is a step in the right direction and needs to be looked into.

Now manufacturers are engaged in the production of nutraceuticals and pharmaceuticals in the same unit. This is going to be recurring investments. While this integration may be beneficial in terms of operational efficiency or product diversification, but it will also create pressure on expenses for the industry. This pressure could stem from various factors such as additional regulatory requirements, specialized equipment needs, or increased research and development costs to ensure compliance and quality in both product lines, noted the industry.

Noting that there have been significant discussions regarding permitting the manufacturing of nutraceuticals within same unit of pharmaceuticals in India, Sanjaya Mariwala, executive chairman and managing director, OmniActive Health Technologies and president of the Association of Herbal and Nutraceutical Manufacturers of India, said that segregating production lines to meet stricter quality standards is a welcome thought, but it will be expensive and can cause supply chain disruptions and reduced exports.

In light of this ongoing development, our view is that a high-standard pharmaceutical plant should be allowed to make nutraceutical products. We see there is no harm in it. Perhaps the opposite may not be acceptable, that is a nutraceutical plant manufacturing pharmaceuticals. Here, a more collaborative approach between regulators and manufacturers is needed, he added.

Understanding industry hurdles and offering incentives are crucial steps. Both sides should strive for rigorous quality control, premarket reviews with clinical trials and accurate labelling to guarantee product integrity. Non-compliance must be met with penalties, pointed out Mariwala.

In addition, a unified regulatory body would streamline processes and inject much-needed order into unethical and flawed practices. This comprehensive strategy would foster a competitive, compliant industry primed for sustainable growth and global leadership, said Mariwala.

Related Posts

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

New Delhi: In a sweeping international crackdown, the Narcotics Control Bureau (NCB) and the US Drug Enforcement Administration (DEA) have dismantled the Indian nerve center of a massive transnational drug…

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Commissioner of Food Safety Tukaram Mundhe said inspections, consumer complaints and surveillance had repeatedly revealed violations Repeated violations of existing food safety regulations by manufacturers and sellers of health supplements…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines